NYC Hormone Replacement Therapy Doctor

NYC Hormone Replacement Therapy Doctor operates under the clinical direction of Dr. Sue Decotiis, a triple board-certified physician holding certifications from the American Board of Internal Medicine, American Board of Obesity Medicine, and American Academy of Antiaging Medicine. Dr. Decotiis also maintains credentials through the Academy of Age Management Medicine, positioning the practice at the intersection of internal medicine expertise and specialized hormone optimization protocols. Located in New York, NY, the clinic serves patients seeking evidence-based approaches to hormonal decline, metabolic dysfunction, and age-related physiological changes through both in-person consultations and telehealth appointments for New York State residents.

The clinic's peptide therapy program centers on growth hormone secretagogue protocols, specifically offering Ipamorelin as a standalone treatment and CJC-1295 both independently and in combination with Ipamorelin. Ipamorelin functions as a selective ghrelin receptor agonist that stimulates pulsatile growth hormone release without significantly affecting cortisol or prolactin levels, making it applicable for patients addressing reduced muscle mass, impaired recovery, or metabolic concerns. CJC-1295, a growth hormone-releasing hormone analog with an extended half-life due to Drug Affinity Complex technology, provides sustained elevation of growth hormone and IGF-1 levels when used alone or synergistically with Ipamorelin for patients requiring more comprehensive growth hormone axis support. These peptide interventions integrate within broader treatment plans that may include bioidentical hormone replacement, testosterone optimization, or medical weight loss protocols tailored to individual laboratory findings and clinical presentations.

Dr. Decotiis structures patient care around comprehensive hormone panels and metabolic assessments, utilizing her internal medicine foundation to evaluate underlying conditions that may influence hormone therapy outcomes. Her obesity medicine certification informs weight management strategies that address insulin resistance, leptin signaling, and metabolic rate optimization alongside hormone correction. The practice treats patients experiencing menopause, perimenopause, and andropause, implementing bioidentical hormone replacement therapy protocols that restore estradiol, progesterone, testosterone, and thyroid hormones to physiologic ranges based on symptom profiles and objective markers. Testosterone replacement therapy for both men and women follows protocols that monitor hematocrit, prostate-specific antigen in male patients, and cardiovascular risk factors, with dosing adjustments made according to trough levels and clinical response rather than arbitrary reference ranges.

Patients initiating care at NYC Hormone Replacement Therapy Doctor undergo initial consultations that include detailed symptom inventories, medication reconciliation, and discussion of treatment goals, followed by laboratory requisitions for baseline hormone levels, metabolic markers, and relevant screening tests. Follow-up protocols typically involve reassessment at 6-8 week intervals during titration phases, with laboratory monitoring to guide dosage modifications and evaluate treatment efficacy. The hybrid consultation model allows New York patients to choose between in-office visits in New York City and telehealth appointments, with peptide prescriptions fulfilled through specialized compounding pharmacies that ship directly to patient addresses. Dr. Decotiis reviews ongoing therapy adjustments personally, maintaining continuity across the treatment timeline rather than delegating follow-up care to ancillary staff.

The practice's focus on age management medicine extends beyond hormone replacement to include evaluation of inflammatory markers, oxidative stress indicators, and metabolic health parameters that influence longevity and functional capacity. Patients receiving peptide therapy typically combine these treatments with nutritional optimization, targeted supplementation, and lifestyle modifications designed to maximize the physiologic benefits of restored growth hormone signaling. The clinic's location in New York, NY provides access to patients throughout the metropolitan area, while telehealth availability ensures continuity of care for established patients and expands access to hormone optimization services across New York State. Dr. Decotiis's triple board certification allows the practice to address complex cases involving metabolic syndrome, treatment-resistant obesity, and multi-system hormone deficiencies that require integrated internal medicine and specialized endocrine expertise.